SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-09-05 20:11
Tx date 2024-09-03
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
1,085,000
Filed 2024-04-11 13:06
Tx date 2024-04-01
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-55,000 vol
835,000
Filed 2023-05-16 16:26
Tx date 2023-05-15
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
890,000
Filed 2023-05-10 11:53
Tx date 2023-05-08
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
650,000
Filed 2023-03-01 13:39
Tx date 2022-12-08
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$60,000
+600,000 vol
$0.10 each
1,367,618
Filed 2023-03-01 13:37
Tx date 2022-12-08
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$60,000
+600,000 vol
$0.10 each
Filed 2022-12-09 14:21
Tx date 2022-12-08
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$60,000
+600,000 vol
$0.10 each
Filed 2023-02-01 19:00
Tx date 2023-02-01
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$1,837
+17,500 vol
$0.105 each
875,632
Filed 2023-01-30 19:49
Tx date 2021-11-07
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-75,000 vol
250,000
Filed 2023-01-30 19:46
Tx date 2023-01-26
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
550,000
Filed 2023-01-17 17:55
Tx date 2023-01-17
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$37,999
+422,222 vol
$0.09 each
858,132
Filed 2022-12-09 14:21
Tx date 2022-12-08
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$60,000
+600,000 vol
$0.10 each
1,240,000
Filed 2022-12-09 14:16
Tx date 2022-12-08
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-60,000
-600,000 vol
$0.10 each
640,000
Filed 2022-08-12 16:27
Tx date 2022-08-10
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+450,000 vol
1,240,000
Filed 2022-07-26 13:35
Tx date 2021-08-13
$AVCR
Avricore Health Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-333,333 vol
0
Filed 2021-08-17 12:15
Tx date 2021-08-12
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-31,500
-180,000 vol
$0.175 each
567,618
Filed 2021-08-16 17:19
Tx date 2021-08-12
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-35,000
-200,000 vol
$0.175 each
Filed 2021-08-16 17:27
Tx date 2021-08-12
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$30,000
+200,000 vol
$0.15 each
747,618
Filed 2021-08-16 17:24
Tx date 2021-08-12
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-30,000
-200,000 vol
$0.15 each
333,333
Filed 2021-08-16 17:19
Tx date 2021-08-12
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-35,000
-200,000 vol
$0.175 each
547,618
Filed 2021-06-16 12:58
Tx date 2021-06-15
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$60,000
+150,000 vol
$0.40 each
325,000
Filed 2021-06-03 11:43
Tx date 2021-06-02
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,899
+33,506 vol
$0.385 each
435,910
Filed 2021-05-27 12:56
Tx date 2021-05-17
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$1,633
+4,355 vol
$0.375 each
402,404
Filed 2021-04-19 23:40
Tx date 2021-04-19
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+75,000 vol
790,000
Filed 2020-08-19 19:57
Tx date 2020-08-18
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$17,249
+95,833 vol
$0.18 each
398,049
Filed 2019-10-31 21:16
Tx date 2019-10-28
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+60,000 vol
715,000
Filed 2019-10-29 15:22
Tx date 2019-10-29
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$14,249
+50,892 vol
$0.28 each
302,216
Filed 2019-09-17 16:28
Tx date 2019-09-13
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Preferred Shares Class A Preference Shares
16 - Acquisition or disposition under a prospectus exemption
$15,000
+37,500 vol
$0.40 each
37,500
Filed 2019-09-17 16:25
Tx date 2010-12-22
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Preferred Shares Class A Preference Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-16 23:03
Tx date 2019-08-14
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$30,000
+200,000 vol
$0.15 each
533,333
Filed 2019-08-16 22:56
Tx date 2019-08-14
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$10,000
+200,000 vol
$0.05 each
747,618
Filed 2019-06-13 10:41
Tx date 2019-04-01
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,300
+55,000 vol
$0.06 each
655,000
Filed 2019-03-19
Tx date 2019-03-15
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.)
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$14,999
+214,285 vol
$0.07 each
547,618
Filed 2019-01-18
Tx date 2019-01-15
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$36,764
+77,398 vol
$0.475 each
251,324
Filed 2019-01-09
Tx date 2016-08-10
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-1,565,334 vol
173,926
Filed 2019-01-09
Tx date 2018-07-30
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
175,000
Filed 2019-01-09
Tx date 2016-12-07
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+75,000 vol
75,000
Filed 2018-05-16
Tx date 2017-12-06
$VANC
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$52,500
+150,000 vol
$0.35 each
600,000
Filed 2018-05-16
Tx date 2017-12-06
$VANC
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$157,500
+450,000 vol
$0.35 each
450,000
Filed 2017-06-28
Tx date 2017-06-26
$VANC
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$66,666
+333,333 vol
$0.20 each
333,333
Filed 2017-06-28
Tx date 2016-01-21
$VANC
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-28
Tx date 2017-06-26
$VANC
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$49,999
+333,333 vol
$0.15 each
333,333
Filed 2017-06-28
Tx date 2016-01-21
$VANC
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-05-12
Tx date 2017-01-27
$VANC
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase

-100,000 vol
0
Filed 2016-11-25
Tx date 2016-11-21
$VANC
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-300,000 vol
100,000
Filed 2016-06-02
Tx date 2016-06-01
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$72,000
+480,000 vol
$0.15 each
1,739,260
Filed 2016-06-02
Tx date 2016-05-31
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-72,000
-900,000 vol
$0.08 each
1,259,260
Filed 2016-04-06
Tx date 2016-04-05
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$125,000
+625,000 vol
$0.20 each
2,159,260
Filed 2016-04-06
Tx date 2016-03-31
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-25,000
-125,000 vol
$0.20 each
1,534,260
Filed 2016-04-06
Tx date 2016-03-31
$RP
RepliCel Life Sciences Inc.
Hall, David M.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-99,999.90
-740,740 vol
$0.135 each
1,659,260
Filed 2016-01-25
Tx date 2016-01-21
$NPH
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$140,000
+400,000 vol
$0.35 each
400,000
Filed 2016-01-25
Tx date 2016-01-21
$NPH
Vanc Pharmaceuticals Inc.
Hall, David M.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report